Immunodeficiency in MS

计划入组 1,500 人 · 首次发布于 2020 年 6 月 25 日

Primitive Immunodeficiency and Pregnancy

计划入组 99 人 · 首次发布于 2020 年 10 月 9 日

Genetic Basis of Immunodeficiency

计划入组 100 人 · 首次发布于 2003 年 2 月 20 日

intravenous immunoglobulin (primary immunodeficiency disease)

HIV specific T-cell therapy

Env 2-3

Theratechnologies

AbbVie CDR (CAD Hedged)

United States

LIVZON PHARMA

China

FDA Grants Priority Review for Leniolisib in Children with Rare Immunodeficiency APDS

Kedrion Biopharma Secures FDA Approval for QIVIGY, First Proprietary IVIG Therapy for Primary Immunodeficiency

Subcutaneous Immunoglobulin 20% Effective for Primary Immunodeficiency